135 related articles for article (PubMed ID: 647696)
1. Synthesis and antitumor activity of 4-demethoxyadriamycin and 4-demethoxy-4' -epiadriamycin.
Di Marco A; Casazza AM; Giuliani F; Pratesi G; Arcamone F; Bernardi L; Franchi G; Giardino P; Patelli B; Penco S
Cancer Treat Rep; 1978 Mar; 62(3):375-80. PubMed ID: 647696
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, antitumor activity, and cardiac toxicity of new 4-demethoxyanthracyclines.
Penco S; Casazza AM; Franchi G; Barbieri B; Bellini O; Podestà A; Savi G; Pratesi G; Geroni C; Di Marco A; Arcamone F
Cancer Treat Rep; 1983; 67(7-8):665-73. PubMed ID: 6575865
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antitumor activity of 4-demethoxydaunorubicin, 4-demethoxy-7,9-diepidaunorubicin, and their beta anomers.
Arcamone F; Bernardi L; Giardino P; Patelli B; Marco A; Casazza AM; Pratesi G; Reggiani P
Cancer Treat Rep; 1976 Jul; 60(7):829-34. PubMed ID: 1009518
[TBL] [Abstract][Full Text] [Related]
4. Effect of various substitutions in positions 1, 2, 3, and 4 of 4-demethoxydaunorubicin and 4-demethoxyadriamycin.
Di Marco A; Casazza AM; Soranzo C; Pratesi G
Cancer Chemother Pharmacol; 1978; 1(4):249-54. PubMed ID: 750112
[TBL] [Abstract][Full Text] [Related]
5. Antitumor spectrum of a new anthracycline, (2"R)-4'-O-tetrahydropyranyladriamycin, and effect on the cellular immune response in mice.
Hisamatsu T; Suzuki K; Sakakibara S; Komuro K; Nagasawa M; Takeuchi T; Umezawa H
Jpn J Cancer Res; 1985 Oct; 76(10):1008-20. PubMed ID: 3935619
[TBL] [Abstract][Full Text] [Related]
6. N-trifluoroacetyladriamycin-14-valerate, an analog with greater experimental antitumor activity and less toxicity than adriamycin.
Israel M; Modest EJ; Frei E
Cancer Res; 1975 May; 35(5):1365-8. PubMed ID: 1054622
[TBL] [Abstract][Full Text] [Related]
7. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of N-trifuloroacetyladriamycin-14-valerate.
Pratesi G; Casazza AM; Di Marco A
Cancer Treat Rep; 1978 Jan; 62(1):105-10. PubMed ID: 626988
[TBL] [Abstract][Full Text] [Related]
9. Antineoplastic activity of azacarbazoles. I. Synthesis and antitumor properties of alpha-carboline and its selected derivatives.
Wieczorek J; Peczyńska-Czoch W; Mordarski M; Kaczmarek L; Nantka-Namirski P
Arch Immunol Ther Exp (Warsz); 1986; 34(3):315-21. PubMed ID: 3592935
[TBL] [Abstract][Full Text] [Related]
10. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P
Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316
[TBL] [Abstract][Full Text] [Related]
11. A fluorine-containing anthracycline (ME2303) as a new antitumor agent against murine and human tumors and their multidrug-resistant sublines.
Tsuruo T; Yusa K; Sudo Y; Takamori R; Sugimoto Y
Cancer Res; 1989 Oct; 49(20):5537-42. PubMed ID: 2790778
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin 14-ethers.
Masi P; Suarato A; Giardino P; Bernardi L; Arcamone F
Farmaco Sci; 1979 Oct; 34(10):907-13. PubMed ID: 510533
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
Fujimoto K; Oka T; Morimoto M
Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218
[TBL] [Abstract][Full Text] [Related]
14. MX2, a morpholino anthracycline, as a new antitumor agent against drug-sensitive and multidrug-resistant human and murine tumor cells.
Watanabe M; Komeshima N; Nakajima S; Tsuruo T
Cancer Res; 1988 Dec; 48(23):6653-7. PubMed ID: 3180075
[TBL] [Abstract][Full Text] [Related]
15. Activity of SC33428, a novel bishydrazone-bridged derivative of 4-demethoxydaunorubicin, against experimental tumors in mice.
Dawson KM
Cancer Res; 1983 Jun; 43(6):2880-3. PubMed ID: 6573953
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J
Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435
[TBL] [Abstract][Full Text] [Related]
17. [Potentiation of chemotherapeutic activity by a Chinese herb medicine juzen-taiho-toh].
Komiyama K; Hirokawa Y; Zhibo Y; Umezawa I; Hata T
Gan To Kagaku Ryoho; 1988 May; 15(5):1715-9. PubMed ID: 3130806
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of new anthracycline antibiotics, aclacinomycin-A and its analogs, and their toxicity.
Hori S; Shirai M; Hirano S; Oki T; Inui T; Tsukagoshi S; Ishizuka M; Takeuchi T; Umezawa H
Gan; 1977 Oct; 68(5):685-90. PubMed ID: 579346
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antitumor properties of pyrazolo [3,4-D] pyrimidine derivatives.
Witkiewicz K; Machoń Z; Mordarski M; Wieczorek J
Pol J Pharmacol Pharm; 1987; 39(6):715-20. PubMed ID: 3503990
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity and hematotoxicity of a new, substituted dihydrobenzoxazine, FK973, in mice.
Shimomura K; Manda T; Mukumoto S; Masuda K; Nakamura T; Mizota T; Matsumoto S; Nishigaki F; Oku T; Mori J
Cancer Res; 1988 Mar; 48(5):1166-72. PubMed ID: 3342397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
